NeueHealth 2024年第四季度GAAP每股收益$(7.41)未达预期$(2.48),销售额为$2.32638亿未达预期$2.51930亿

财报速递
20 Mar
NeueHealth (NYSE:NEUE)报告的季度每股亏损为$(7.41),比分析师的共识估计$(2.48)低198.79%。这比去年同期每股收益$19.54减少了137.92%。公司报告的季度销售额为$2.32638亿,比分析师的共识估计$2.51930亿低7.66%。这比去年同期销售额$2.92871亿减少了20.57%。

以上内容来自Benzinga Earnings专栏,原文如下:

NeueHealth (NYSE:NEUE) reported quarterly losses of $(7.41) per share which missed the analyst consensus estimate of $(2.48) by 198.79 percent. This is a 137.92 percent decrease over earnings of $19.54 per share from the same period last year. The company reported quarterly sales of $232.638 million which missed the analyst consensus estimate of $251.930 million by 7.66 percent. This is a 20.57 percent decrease over sales of $292.871 million the same period last year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10